 16 PM / in 12 minutes BRIEF-Rexahn Pharma Receives Notice Of Allowance For New U.S. Patent Reuters Staff 1 Min Read 
Jan 29 (Reuters) - Rexahn Pharmaceuticals Inc: 
* REXAHN PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FOR A NEW U.S. PATENT COVERING THE USE OF RX-5902 (SUPINOXINâ„¢)  